Aortic Center, University of Southern California Cardio-Vascular Thoracic Institute, Los Angeles, CA 90033, USA.
J Vasc Surg. 2011 Nov;54(5):1345-51. doi: 10.1016/j.jvs.2011.04.044. Epub 2011 Aug 11.
This study was conducted to determine the incidence of disease progression and the need for subsequent revascularization procedures in patients with Takayasu arteritis (TA).
From 1980 to 2009, all patients with TA who underwent an initial revascularization procedure for end-organ ischemia were identified. The incidence of subsequent revascularization in another vascular bed or revision of the initial procedure was determined.
Forty patients (36 women; mean age, 35) underwent an initial revascularization procedure. Indications for the initial procedure were hypertension in 20, renal dysfunction in 9, extremity ischemia in 6, and stroke/transient ischemic attack in 5. The initial revascularization consisted of 60 bypass procedures and 4 endovascular interventions. During a mean follow-up of 6.4 years, progression of TA in another vascular bed or stenosis/occlusion of the initial revascularization procedure occurred in 16 patients (40%). Five patients with progression required one procedure, whereas 11 required two or more surgical interventions. Procedures required were renal in 12, cerebrovascular in 8, extremity in 8, aortic reconstruction in 5, and mesenteric in 1. Postoperative/30-day morbidity was 14%, and one operative death occurred. Actuarial survival was 94% at 1 year and 85% at 5 years after the remedial procedure.
TA progression is common in patients who require revascularization for end-organ ischemia. This finding emphasizes the need for global lifelong vascular surveillance of all patients who undergo surgical intervention for TA. The effect of steroid and immunosuppressive therapy on reducing reoperation requires further study.
本研究旨在确定大动脉炎(TA)患者发生疾病进展和需要后续血运重建的发生率。
1980 年至 2009 年,对所有因终末器官缺血而行初次血运重建术的 TA 患者进行了识别。确定了另一血管床发生再次血运重建或初始手术修正的发生率。
40 例患者(36 例女性;平均年龄 35 岁)接受了初次血运重建术。初次血运重建的适应证为高血压 20 例、肾功能不全 9 例、肢体缺血 6 例和脑卒中/短暂性脑缺血发作 5 例。初次血运重建包括 60 例旁路手术和 4 例血管内介入治疗。平均 6.4 年的随访中,16 例(40%)患者出现了另一血管床的 TA 进展或初始血运重建的狭窄/闭塞。5 例进展患者需要进行 1 次手术,而 11 例患者需要进行 2 次或更多次手术。需要进行的手术包括肾脏 12 例、脑血管 8 例、肢体 8 例、主动脉重建 5 例和肠系膜 1 例。术后/30 天发病率为 14%,1 例手术死亡。补救手术后 1 年和 5 年的累积生存率分别为 94%和 85%。
因终末器官缺血而行血运重建的 TA 患者中,TA 进展较为常见。这一发现强调了对所有接受 TA 手术干预的患者进行终生血管全面监测的必要性。类固醇和免疫抑制治疗对减少再次手术的影响需要进一步研究。